Roflumilast is prescribed for:
- Reducing COPD exacerbations
- Severe COPD with chronic bronchitis
- Patients with history of frequent exacerbations
- Respiratory anti-inflammatory therapy
NOT a bronchodilator - works by reducing inflammation.
Generic Name: Roflumilast
Brand Names: Daliresp
Roflumilast is an oral PDE4 inhibitor that reduces COPD exacerbations in patients with severe disease.
Roflumilast is prescribed for:
NOT a bronchodilator - works by reducing inflammation.
Common side effects:
Serious side effects:
Roflumilast is an oral phosphodiesterase-4 inhibitor that reduces airway inflammation in COPD.
Unlike inhalers, roflumilast doesn't provide immediate symptom relief. It reduces inflammation to prevent exacerbations.
Best for severe COPD patients with chronic bronchitis phenotype and frequent exacerbations despite inhaled therapy.
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Roflumilast? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.